Michael Stucky

Michael Stucky has held a variety of roles in the business world since 2011. Michael began their career as Co-founder and CFO of GlycoVaxyn AG, where they oversaw the company's financial strategy, supported fundraising efforts, negotiated collaboration agreements, evaluated strategic decisions, and supported the management of the Company. In 2015, the company was sold to GSK. Stucky then became Co-founder and Executive Director of Anjarium Biosciences in 2017. In 2019, they were Entrepreneur In Residence at the University of Zurich and Co-founder & Chairman of Auxivo AG. Since 2015, they have been a Startup Coach for Innosuisse - Schweizerische Agentur für Innovationsförderung and a Coach & Mentor at ETH Zurich, where they advise young entrepreneurs on all aspects related to starting a company. In 2021, they joined FenX as a Member Board of Directors, and since February 2022 they have been Chair. Most recently, in 2022, Stucky became a Venture Partner at Serpentine Ventures.

Michael Stucky obtained a Masters of Science in Management from Stanford University Graduate School of Business in 2009, with a focus in Management. Prior to that, they earned an MBA from University of Zurich between 1993 and 1999, with a focus in Finance.